Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
शेयरों में रैंक #33275
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
शेयर मूल्य
$5.39
मार्केट कैप
$7.87M
बदलाव (1 दिन)
-2.45%
बदलाव (1 वर्ष)
5.80%
देश
US
व्यापार CNS Pharmaceuticals, Inc. (CNSP)

श्रेणी

CNS Pharmaceuticals, Inc. (CNSP) के लिए EPS
2026 TTM तक का EPS: 0
CNS Pharmaceuticals, Inc. की नवीनतम वित्तीय रिपोर्टों और शेयर मूल्य के अनुसार, कंपनी का वर्तमान EPS (TTM) 0 है। 2026 के अंत में, कंपनी का EPS 0 था, जो 2026 के EPS 0 के के बराबर था।
CNS Pharmaceuticals, Inc. के लिए 2026 से 2026 तक का EPS इतिहास
प्रत्येक वर्ष के अंत में EPS
वर्ष EPS परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए EPS
कंपनी EPS EPS अंतर देश
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE